Massimo Conte
Overview
Explore the profile of Massimo Conte including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
100
Citations
1111
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Perrone A, Lakatos K, Pegoraro F, Trambusti I, Fotzi I, Selvi V, et al.
Pediatr Blood Cancer
. 2022 Nov;
70(2):e30064.
PMID: 36317710
Introduction: Radiographic skeletal survey (R-SS) is the standard imaging technique for the initial staging of Langerhans cell histiocytosis (LCH). Whole-body magnetic resonance imaging (WB-MRI) has been proposed as an effective,...
12.
Bottino C, Della Chiesa M, Sorrentino S, Morini M, Vitale C, Dondero A, et al.
Cancers (Basel)
. 2022 Oct;
14(19).
PMID: 36230485
High-risk neuroblastomas (HR-NB) still have an unacceptable 5-year overall survival despite the aggressive therapy. This includes standardized immunotherapy combining autologous hemopoietic stem cell transplantation (HSCT) and the anti-GD2 mAb. The...
13.
Cangelosi D, Brignole C, Bensa V, Tamma R, Malaguti F, Carlini B, et al.
EBioMedicine
. 2022 Oct;
85:104300.
PMID: 36209521
Background: Neuroblastoma (NB) represents the most frequent form of extra-cranial solid tumour of infants, responsible for 15% of childhood cancer deaths. Nucleolin (NCL) prognostic value in NB was investigated. Methods:...
14.
Papadakis V, Segura V, Conte M, Plantaz D, Di Cataldo A, Schleiermacher G, et al.
Cancers (Basel)
. 2022 Aug;
14(16).
PMID: 36011005
To assess whether expectant observation of infants ≤ 90 days old with small suprarenal masses (sSRMs) could avoid unnecessary surgery without impacting outcome. Infants ≤ 90 days with a ≤...
15.
Fiz F, Bottoni G, Bini F, Cerroni F, Marinozzi F, Conte M, et al.
Pediatr Blood Cancer
. 2022 Aug;
69(11):e29910.
PMID: 35920594
Purpose: To evaluate the prognostic value of texture analysis of the primary tumour with fluorine-dihydroxyphenylalanine positron emission tomography/X-ray computed tomography ( F-DOPA PET/CT) in patients affected by high-risk neuroblastoma (HR-NBL)....
16.
Barco S, Lavarello C, Cangelosi D, Morini M, Eva A, Oneto L, et al.
Front Oncol
. 2022 Jun;
12:845936.
PMID: 35756625
Neuroblastoma (NB) is the most common extracranial malignant tumor in children. Although the survival rate of NB has improved over the years, the outcome of NB still remains poor for...
17.
Uva P, Bosco M, Eva A, Conte M, Garaventa A, Amoroso L, et al.
Cancers (Basel)
. 2021 Jul;
13(11).
PMID: 34199959
Neuroblastoma (NB) is one of the deadliest pediatric cancers, accounting for 15% of deaths in childhood. Hypoxia is a condition of low oxygen tension occurring in solid tumors and has...
18.
Brignole C, Bensa V, Fonseca N, Del Zotto G, Bruno S, Cruz A, et al.
J Exp Clin Cancer Res
. 2021 Jun;
40(1):180.
PMID: 34078433
Background: Neuroblastoma (NB) represents the most frequent and aggressive form of extracranial solid tumor of infants. Nucleolin (NCL) is a protein overexpressed and partially localized on the cell surface of...
19.
Dondero A, Morini M, Cangelosi D, Mazzocco K, Serra M, Spaggiari G, et al.
J Immunother Cancer
. 2021 Apr;
9(4).
PMID: 33795387
Background: High-risk neuroblastomas (HR-NBs) are rare, aggressive pediatric cancers characterized by resistance to therapy and relapse in more than 30% of cases, despite using an aggressive therapeutic protocol including targeting...
20.
DAngelo P, Pasquale M, Barretta F, Affinita M, Conte M, DallIgna P, et al.
Pediatr Blood Cancer
. 2020 Nov;
68(3):e28812.
PMID: 33219741
Purpose: To evaluate clinical features at diagnosis, prognostic factors, and outcomes of malignant sacrococcygeal germ cell tumors (SC-GCTs) in patients enrolled in the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) TCG...